Detailed information
| LncRNA Name | GAS5 |
| Variant Type | SNP |
| Variant ID | rs6790 |
| Species | human |
| Circulating | ✕ |
| Survival | ✓ |
| CeRNA | ✕ |
| Methylation | ✕ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | nasopharyngeal cancer |
| LncRNA Target Gene | NA |
| Tissue | NPC tissues |
| Experiment | DNA Extraction and genotyping, SNPs selections etc. |
| Function Description | the potential role of lncRNA GAS5 polymorphisms rs2067079 and rs6790 as predictive biomarkers for chemoradiotherapy induced toxic reactions in NPC patients.This decrement was significantly correlated with poor survival in HCC patients. |
| Pubmed ID | 28977945 |
| Year | 2017 |
| Title | Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients. |
| External Links | |
|---|---|
| Links For GAS5 | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For nasopharyngeal cancer | OMIM Cosmic |
| Links For rs6790 | dbSNP ClinVar OMIM |